Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ORENCIA
- Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route
- Subcutaneous Abatacept in Renal Transplant Recipients
- Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD
- Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia
- Abatacept in Immune Checkpoint Inhibitor Myocarditis
- A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV)
- Abatacept Conversion in Kidney Transplantation
- Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
- Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis
- Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
- Immune Modulators for Treating COVID-19
- Abatacept for the Treatment of Giant Cell Arteritis
- Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
- Abatacept in Individuals Who aRe Considered At Risk of Developing Inflammatory Arthritis
- Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
- Abatacept for Treatment of Recurrent or de Novo Autoimmune Hepatitis
- Early Markers of Disease and Response to Therapy
- Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant
- A Study to Evaluate Biomarkers to Predict Efficacy of Abatacept in Rheumatoid Arthritis
- Abatacept in Patients With Birdshot HLA A29 Uveitis
- Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA)
- Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation in Patients With Hematologic Malignancy
- Safety and Efficacy of Abatacept in IgG4-Related Disease
- EFFECTS OF ABATACEPT on the Progression to Rheumatoid Arthritis(PALABA Study)
- Effects of Abatacept on Myocarditis in Rheumatoid Arthritis
- Abatacept to Silence Anti-citrullinated Protein Antibody-expressing B Cells in Rheumatoid Arthritis (ASCARA)
- Abatacept, Ixazomib Citrate, and Dexamethasone in Treating Patients With Multiple Myeloma Resistant to Chemotherapy
- Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
- Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate Responders
- Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease
- APRIL (AbatacePt in Rheumatoid Arthritis-ILD)
- Trial of Orencia in Patients With Myasthenia Gravis
- Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease
- Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously
- Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia
- A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
- Survey on Long-Term Use of ORENCIA® Intravenous Infusion 250mg
- Use-Results Survey for ORENCIA® Subcutaneous Injection 125mg Syringe 1mL
- Abatacept in Juvenile Dermatomyositis
- Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis
- Vaccination Against Pneumococcal in Naïve Abatacept Rheumatoid Arthritis Patients
- Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease Activity
- Abatacept for SLE Arthritis (IM101-330)
- Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept
- Open-label Pilot Study of Abatacept for the Treatment of Vitiligo
- Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation
- A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
- Long Term Experience With Abatacept in Routine Clinical Practice
- Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)
- Long-term Experience With Abatacept SC in Routine Clinical Practice
- Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome
- Abatacept vs Placebo in RA Patients With Hepatitis B on Entecavir Background
- Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study
- An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata
- Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris
- Bone Marrow Transplant With Abatacept for Non-Malignant Diseases
- Entecavir for Biological Agents Associated HBV Reactivation in Inflammatory Arthritis Patients
- Study to Characterize the Pharmacokinetics of a Single Dose of SC Abatacept 125 mg Using the BD Autoinjector or the Prefilled Syringe
- Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis
- Methotrexate-Inadequate Response Autoinjector Device Sub Study
- Abatacept as GVHD Prophylaxis Phase 2
- Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid Arthritis
- Description of Joint Population and Assessment of Impact on Health Status of Orencia in Patients With Rheumatoid Arthritis in France. A Database Analysis Based on SFR's ORA Long-term Cohort Study
- A Pilot Study of the Safety and Efficacy of Abatacept Injections in the Treatment of Behcet's Syndrome
- A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of Action
- Ultrasound and Withdrawal of Biological DMARDs in Rheumatoid Arthritis
- Korean Post-marketing Surveillance for Orencia®
- Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction
- A Study to Assess the Receptor Occupancy of CD86 and CD80 in Subjects With Rheumatoid Arthritis Initiating Abatacept
- Abatacept Treatment in Polymyositis and Dermatomyositis
- Abatacept in the Treatment of Uveitis
- Study on the Safety of Abatacept in Relapsing Polychondritis
- Pharmacokinetic Study to Compare the Blood Levels of Low vs High Metal Manufacture of Abatacept
- Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis
- Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT
- Abatacept Versus Adalimumab Head-to-Head
- Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine Therapy
- The Effect of Inhibition of B7-mediated Costimulation on Allergic Airway Inflammation in Mild Atopic Asthmatics
- Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
- Safety Study of Abatacept to Treat Refractory Sarcoidosis
- Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg
- Phase IIIB Switching From Intravenous to Subcutaneous Study
- Methotrexate-Inadequate Response Study
- Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis
- Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis
- Phase IIIB Subcutaneous Missed Dose Study
- Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis
- A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
- A Study of Abatacept in Patients With Active Ulcerative Colitis
- A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
- A Study of Abatacept in Patients With Active Crohn's Disease
- A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate
- Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers
- Islet Transplantation Using Abatacept
- Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA)
- An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy
- Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy
- Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients
- Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone
- BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis
- Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis
- A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis
- Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.
- A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple Sclerosis
Clinical trials list
click for details